Cytarabine is a Intravenous; Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Hospira, Inc.. The primary component is Cytarabine.
Product ID | 61703-304_7eb21af3-b7da-49c5-85f5-3de0dff448b9 |
NDC | 61703-304 |
Product Type | Human Prescription Drug |
Proprietary Name | Cytarabine |
Generic Name | Cytarabine |
Dosage Form | Injection, Solution |
Route of Administration | INTRAVENOUS; SUBCUTANEOUS |
Marketing Start Date | 1994-02-28 |
Marketing Category | ANDA / ANDA |
Application Number | ANDA072945 |
Labeler Name | Hospira, Inc. |
Substance Name | CYTARABINE |
Active Ingredient Strength | 20 mg/mL |
Pharm Classes | Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 1994-02-28 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | ANDA |
Application Number | ANDA072945 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 1994-02-28 |
Ingredient | Strength |
---|---|
CYTARABINE | 20 mg/mL |
SPL SET ID: | 21e8e8e6-3f85-4fdd-8452-c9d14d2ef69a |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
61703-303 | CYTARABINE | CYTARABINE |
61703-304 | Cytarabine | CYTARABINE |
61703-305 | Cytarabine | CYTARABINE |
61703-319 | Cytarabine | CYTARABINE |
63323-120 | Cytarabine | CYTARABINE |
67457-452 | Cytarabine | Cytarabine |
67457-454 | Cytarabine | Cytarabine |
67457-455 | cytarabine | cytarabine |
68083-337 | Cytarabine | Cytarabine |
68083-343 | Cytarabine | Cytarabine |
71288-108 | Cytarabine | Cytarabine |
71288-109 | Cytarabine | Cytarabine |
71288-168 | Cytarabine | Cytarabine |
71288-169 | Cytarabine | Cytarabine |